Drug
Ctx 009
Ctx 009: highest development phase Phase 2/3, developed by Compass Pathways. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Compass Pathways
Trials
| Drug | Phase | Indication |
|---|---|---|
| CTX-009 NCT05506943 | Phase 2/3 | Biliary Tract Cancer |
Latest
No recent events.
Follow Ctx 009 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.